PGK1 and breast carcinoma: In conclusion, the advancements in research on the glycolytic pathway and the glycolysis-related gene PGK1 in the context of breast cancer under hypoxic conditions offer valuable insights into the mechanisms and therapeutic targets of metabolic reprogramming in breast cancer.